Humate-P regulatory update

EMA's CHMP issued a positive opinion recommending approval of Voncento from CSL's CSL Behring subsidiary to treat and prevent bleeding in patients with hemophilia A and von Willebrand disease (vWD). The product is recommended to treat hemorrhage or prevent and treat surgical bleeding in vWD patients when desmopressin treatment alone is ineffective or contraindicated, and as prophylaxis and treatment of bleeding in patients with hemophilia A. ...